Cybersecurity has become a critical regulatory requirement for medical devices worldwide. This is mainly due to increasing device connectivity, software integration, cloud platforms, and cybersecurity threats. Most regulators now expect manufacturers to implement cybersecurity throughout the entire product lifecycle. Regulatory expectations are aligned with IMDRF cybersecurity principles, risk management practices, secure development lifecycle (SDL), vulnerability disclosure, and continuous monitoring. In this blog, we have presented the global regulations for cybersecurity in medical devices.
Global regulations for cybersecurity in medical devices
Across all major jurisdictions, cybersecurity in medical devices is no longer viewed solely as an IT issue. However, it is a patient safety and regulatory compliance requirement. Common global expectations now include secure-by-design development, cybersecurity risk management, security testing, vulnerability disclosure. Additionally, they require software maintenance, SBOM transparency, and continuous post-market surveillance throughout the device lifecycle.
Manufacturers should adopt a secure-by-design development approach from project initiation. Moreover, cybersecurity risk management must be integrated with overall product safety processes. Threat modeling helps identify vulnerabilities that could affect safety and performance. Security testing should verify the effectiveness of implemented cybersecurity controls. Vulnerability monitoring enables rapid response to newly discovered cyber threats. Furthermore, post-market surveillance ensures ongoing cybersecurity compliance throughout the device lifecycle.
1. United States (FDA)
The FDA classifies connected medical products as cyber devices when cybersecurity functionality is necessary for safety. Manufacturers must implement cybersecurity in medical devices throughout the device’s entire lifecycle, from design through post-market maintenance. Premarket submissions require cybersecurity risk assessments, threat modeling, and security control documentation. A Software Bill of Materials (SBOM) must identify software components and potential cybersecurity vulnerabilities. Manufacturers must establish processes for vulnerability monitoring, coordinated disclosure, and timely remediation. Failure to provide required cybersecurity information can result in refusal of submission acceptance.
Key focus
- Secure-by-design approach
- Post-market vulnerability management
- Coordinated vulnerability disclosure
- Continuous cybersecurity maintenance
Key regulations and guidance
- FD&C Act Section 524B (Cyber Devices)
- FDA Guidance: Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions
- FDA Refuse-to-Accept (RTA) policy for cyber devices
2. Health Canada
Health Canada considers cybersecurity in medical devices a critical component of medical device safety and effectiveness. Manufacturers must address cybersecurity risks during product design and development activities. Moreover, premarket submissions should include cybersecurity risk management and mitigation strategies. Additionally, evidence of verification and validation testing must demonstrate cybersecurity control effectiveness. Manufacturers should provide procedures for software updates and vulnerability management. Furthermore, continuous monitoring helps identify and address emerging cybersecurity threats after market authorization.
Key focus
- Secure design
- Risk management
- Traceability
- Lifecycle monitoring
- Premarket cybersecurity evidence
Key guidance
- Guidance Document: Pre-market Requirements for Medical Device Cybersecurity (2019)
3. European Union (EU MDR)
EU MDR incorporates cybersecurity requirements through its General Safety and Performance Requirements. Manufacturers must protect devices against unauthorized access, misuse, and malicious cyberattacks. Cybersecurity risks must be included within the overall device risk management process. Security controls should reflect current technological standards and state-of-the-art practices. Moreover, manufacturers must validate cybersecurity functions through documented testing and verification activities. Post-market surveillance programs should continuously monitor cybersecurity incidents and vulnerabilities.
Key focus
- Secure-by-design
- Security risk management
- Post-market surveillance
- Continuous vulnerability management
Key guidance
- EU MDR 2017/745
- Annex I General Safety and Performance Requirements (GSPRs)
- MDCG 2019-16 Rev.1 Guidance on Cybersecurity
4. India (CDSCO)
CDSCO addresses cybersecurity in medical devices primarily through software and medical device regulatory requirements. Additionally, manufacturers must apply risk management principles to connected and software-based devices. Software validation and verification activities should demonstrate product safety and reliability. Cybersecurity considerations are increasingly important for SaMD and AI-enabled devices. Furthermore, quality management systems should include controls for software security and maintenance. Post-market surveillance activities help identify cybersecurity issues affecting device performance.
Key focus
- Software validation
- Risk-based classification
- Secure software development
- Post-market monitoring
- AI/ML cybersecurity considerations
Key guidance
- Medical Devices Rules (MDR), 2017
- CDSCO Guidance Document on Medical Device Software (MDSW)
5. Japan (PMDA/MHLW)
Japan requires manufacturers to address cybersecurity throughout the medical device lifecycle. Cybersecurity risk management must identify threats, vulnerabilities, and potential patient impacts. Manufacturers should implement secure software development and testing methodologies. Security controls must be validated to demonstrate adequate protection against cyber threats. Vulnerability management programs support timely detection and correction of security issues. Regulatory expectations align closely with international cybersecurity and risk management principles.
Key focus
- Total product lifecycle management
- Shared responsibility model
- Security testing
- Vulnerability correction
- SBOM and software transparency
Key guidance
- Pharmaceuticals and Medical Devices (PMD) Act
- MHLW Cybersecurity Notifications
- Essential Principles Article 12(3)
6. Australia (TGA)
The TGA follows a lifecycle-based approach to medical device cybersecurity management. Manufacturers must integrate cybersecurity considerations into design and development processes. Additionally, risk assessments should evaluate potential cybersecurity threats and their clinical consequences. Security controls require verification through testing and documented validation activities. Manufacturers should establish procedures for vulnerability monitoring and software updates. Post-market activities ensure continued cybersecurity effectiveness throughout the device lifecycle.
Key focus
- Risk-based compliance
- Secure development lifecycle
- Threat monitoring
- Security updates and patching
- Post-market cybersecurity management
Key guidance
- Complying with Medical Device Cyber Security Requirements
7. Saudi Arabia (SFDA)
The SFDA requires cybersecurity in medical devices to be incorporated during medical device design and development. Manufacturers must perform cybersecurity risk assessments before market authorization applications. Moreover, technical documentation should demonstrate implemented cybersecurity controls and mitigation measures. Vulnerability management processes must support identification and remediation of security weaknesses. Manufacturers should monitor emerging threats and maintain cybersecurity throughout product use. The SFDA framework aligns with international lifecycle-based cybersecurity regulatory approaches.
Key focus
- Secure product design
- Lifecycle cybersecurity management
- Vulnerability monitoring
- Premarket cybersecurity documentation
- Risk-based controls
Key guidance
- MDS-G38: Guidance to Pre-Market Cybersecurity of Medical Devices
- MDS-G36: Guidance to Medical Devices Cybersecurity for Healthcare Providers
Why does cybersecurity compliance in medical devices matter?
- Protects patient safety: Cybersecurity weaknesses can directly affect device functionality and clinical performance. Strong cybersecurity controls help prevent patient harm caused by cyberattacks.
- Ensures regulatory compliance: Global regulators increasingly require cybersecurity evidence during product approvals. Compliance demonstrates that cybersecurity risks are properly managed throughout the lifecycle.
- Protects sensitive health data: Medical devices often process and store patient health information. Cyberattacks can result in data breaches and privacy violations. Cybersecurity measures help maintain confidentiality, integrity, and availability of data.
- Reduces risk of unauthorized access: Connected medical devices are potential targets for hackers and malicious actors. Unauthorized access can compromise device settings, software, or network communications. Security controls help restrict access to authorized users and systems only.
- Supports device reliability and performance: Cybersecurity incidents can disrupt normal device operation and availability. Reliable security controls help maintain consistent and predictable performance. This ensures healthcare providers can depend on devices during critical situations.
- Strengthens post-market risk management: New cybersecurity vulnerabilities emerge throughout a device’s operational life. Manufacturers must continuously monitor, assess, and address evolving threats. Effective compliance programs support timely remediation and security updates.
- Protects manufacturer reputation: Security incidents can significantly damage customer confidence and market credibility. Healthcare organizations prefer products with proven cybersecurity safeguards. Strong compliance demonstrates commitment to quality, safety, and trust.
- Supports connected healthcare ecosystems: Modern medical devices communicate with networks, software, and cloud platforms. Cybersecurity helps secure data exchange across connected healthcare environments. Protected connectivity enables safer and more effective digital healthcare delivery.
Pharmadocx Consultants will help you easily comply with global regulations for cybersecurity in medical devices
At Pharmadocx Consultants, we have a rich experience in medical device regulatory consulting, with proven expertise in navigating complex global compliance frameworks. Our team has successfully guided manufacturers in achieving regulatory approvals across the US, EU, Canada, and India. Our comprehensive services will help you easily comply with global regulations for cybersecurity in medical devices. Drop an email at [email protected] or call/Whatsapp on 9996859227 to get started.
